Metastatic melanoma is a complex and deadly disease. Due to its complexity, the
development of novel therapeutic strategies to inhibit metastatic melanoma remains an …

Cutaneous melanoma arises from proliferating melanocytes, cells specialized in the
production of melanin. This property means melanin can be considered as a target for …

Invasive aspergillosis is a critical complication in immunocompromised patients with
hematologic malignancies or with viral pneumonia caused by influenza virus or SARS‑CoV …

Melanin is one of the representative biomarkers of malignant melanoma and a potential
target for diagnosis and therapy. With advancements in chemistry and radiolabeling …

Benzamide (BZA), a small molecule that can freely cross cell membranes and bind to
melanin, has served as an effective targeting group for melanoma theranostics. In this study …

Malignant melanoma has an aggressive nature and a high metastatic propensity resulting in
the highest mortality rate of any skin cancer. In this study, we synthesized 18 F-labeled …

Melanoma, with its steadily rising global incidence, is characterized by high invasiveness,
leading to poor prognosis in advanced stages. There remains an unmet clinical need for the …

Melanoma is a deadly disease that often exhibits relentless progression and can have both
early and late metastases. Recent advances in immunotherapy and targeted therapy have …

Malignant melanoma is accounting for most of skin cancer-associated mortality. The
incidence of melanoma increased every year worldwide especially in western countries …

Polyamine metabolism dysregulation is a hallmark of many cancers, offering a promising
avenue for early tumor theranostics. This study presents the development of a nuclear probe …